LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

BioAge Labs, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERBIOA
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / BIOA COVERAGE

What’s moving BioAge Labs, Inc. now

Current reporting with the operating signal separated from the noise.

01
Analysts Have Conflicting Sentiments on These NA Companies: BioAge Labs, Inc. (BIOA) and adidas AG (GB:0OLD)

Analysts Have Conflicting Sentiments on These NA Companies: BioAge Labs, Inc. (BIOA) and adidas AG (GB:0OLD)

The story matters when it changes BioAge Labs, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Needham Keeps Their Buy Rating on BioAge Labs, Inc. (BIOA)

Needham Keeps Their Buy Rating on BioAge Labs, Inc. (BIOA)

The story matters when it changes BioAge Labs, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Is BioAge Labs, Inc. (BIOA) Stock Positioned for Growth With New Phase 2 Cardiovascular Study Initiation?

Is BioAge Labs, Inc. (BIOA) Stock Positioned for Growth With New Phase 2 Cardiovascular Study Initiation?

Investors are testing whether BioAge Labs, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
BioAge Labs, Inc. (BIOA) Discusses Phase I Results and Development Plans for BGE-102 NLRP3 Inhibitor Transcript

BioAge Labs, Inc. (BIOA) Discusses Phase I Results and Development Plans for BGE-102 NLRP3 Inhibitor Transcript

The story matters when it changes BioAge Labs, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
BioAge Labs, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm

BioAge Labs, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm

The story matters when it changes BioAge Labs, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
06
Deadline Approaching: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith

Deadline Approaching: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith

The story matters when it changes BioAge Labs, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest BIOA filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-08 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-06 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-24 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-12 · Period 2026-06-10SEC ↗8-KMaterial company eventFiled 2026-05-08 · Period 2026-05-08SEC ↗8-KMaterial company eventFiled 2026-03-24 · Period 2026-03-24SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-21 · Period 2026-06-10SEC ↗4Official SEC filingFiled 2026-07-01 · Period 2026-06-29SEC ↗
EARNINGS / QUARTERLY TRACKER

BioAge Labs, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.